Capital World Investors Novavax Inc Transaction History

Capital World Investors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $10.7 Million - $22.2 Million	-294,294 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $40.5 Million - $83 Million	-580,854 Reduced 66.37%	294,294 $21.7 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $81.2 Million - $132 Million	-603,553 Reduced 40.82%	875,148 $125 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $153 Million - $233 Million	860,867 Added 139.34%	1,478,701 $307 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $64.2 Million - $182 Million	-567,908 Reduced 47.89%	617,834 $112 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $2.31 Million - $4.1 Million	29,363 Added 2.54%	1,185,742 $132 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $56.6 Million - $127 Million	712,151 Added 160.31%	1,156,379 $125 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $6.16 Million - $37.1 Million	444,228 New	444,228 $37 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $676M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.